Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: November 10, 2017

NIH Weekly Funding Opportunities, Notices: November 10, 2017



Notices
Requests for Applications

     

  • Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) 
    (RFA-AG-18-021)
    National Institute on Aging
    Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01- Clinical Trial Optional)
    (RFA-DK-17-038)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. 

     

  • Environmental Health Sciences Core Centers (EHS CC) (P30 Clinical Trial Optional)
    (RFA-ES-18-003)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): April 17, 2018, April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Contraception Research Centers Program (U54)
    (RFA-HD-18-035)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): January 9, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required)
    (RFA-HL-18-027)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): February 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed)
    (RFA-MD-18-002)
    National Institute on Minority Health and Health Disparities 
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
    (RFA-MH-18-510)
    National Institute of Mental Health
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): March 15, 2018; December 7, 2018; August 7, 2019; April 7, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates 

     

  • NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed)
    (RFA-MH-18-600)
    National Institute of Mental Health
    NIH Blueprint for Neuroscience Research
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 22, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed
    (RFA-MH-18-610)
    National Institute of Mental Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed)
    (RFA-MH-18-611)
    National Institute of Mental Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): January 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Translational Neural Devices (UG3/UH3 - Clinical Trial Required)
    (RFA-NS-18-011)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 21, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Translational Neural Devices (U44 - Clinical Trial Required)
    (RFA-NS-18-012)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 21, 2018; June 21, 2018; October 22, 2018; February 21, 2019; June 21, 2019; October 21, 2019; February 21, 2020; June 22, 2020; and October 21, 2020 , by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Program Announcements